CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized
CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized of 0 shares for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized · last filed 2018-03-08
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2013-12-31 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2013-09-30 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2013-06-30 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for the quarter ending 2013-03-31 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2017 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2016 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2015 was 0.00 shares.
- CURIS, INC. share-based compensation arrangement by share-based payment award, number of additional shares authorized for fiscal 2014 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized 12 month |
|---|---|---|---|---|
| 2017-12-31 | 0.00 shares 10-K · filed 2018-03-08 | |||
| 2016-12-31 | 0.00 shares 10-K · filed 2017-03-09 | |||
| 2015-12-31 | 0.00 shares 10-K · filed 2016-02-29 | |||
| 2014-12-31 | 0.00 shares 10-K · filed 2015-02-24 | |||
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | 0.00 shares derived: sum of 2 quarters · filed 2014-03-13 | 0.00 shares derived: sum of 3 quarters · filed 2014-03-13 | 0.00 shares 10-K · filed 2014-03-13 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-12 | 0.00 shares 10-Q · filed 2013-11-12 | |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 0.00 shares 10-Q · filed 2013-08-08 | ||
| 2013-03-31 | 0.00 shares 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | 0.00 shares 10-K · filed 2013-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |